Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany (Q35637894)

9 August 2017

Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany (English)

1 reference

9 August 2017

0 references

1 reference

1 reference

1 reference

ankylosing spondylitis

1 reference

systemic lupus erythematosus

inferred from title

0 references

author

Dörte Huscher

1 reference

ORCID Public Data File 2021

author name string

D Huscher

1

1 reference

9 August 2017

S Merkesdal

2

1 reference

9 August 2017

K Thiele

3

1 reference

9 August 2017

H Zeidler

4

1 reference

9 August 2017

M Schneider

5

1 reference

9 August 2017

A Zink

6

1 reference

9 August 2017

German Collaborative Arthritis Centres

7

1 reference

9 August 2017

language of work or name

English

0 references

publication date

15 March 2006

1 reference

Annals of the Rheumatic Diseases

9 August 2017

1 reference

9 August 2017

65

1 reference

9 August 2017

9

1 reference

9 August 2017

1175-1183

1 reference

Indirect cost assessment in patients with rheumatoid arthritis (RA): comparison of data from the health economic patient questionnaire HEQ-RA and insurance claims data

9 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798296

Treatment continuation in patients receiving biological agents or conventional DMARD therapy

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798296

Cost effectiveness of etanercept (Enbrel) in combination with methotrexate in the treatment of active rheumatoid arthritis based on the TEMPO trial

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798296

Direct costs of ankylosing spondylitis and its determinants: an analysis among three European countries

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798296

Costs of rheumatoid arthritis in Germany: a micro-costing approach based on healthcare payer's data sources

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798296

Ankylosing spondylitis: what is the cost to society, and can it be reduced?

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798296

Cost of illness studies in rheumatic diseases

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798296

The national database of the German Collaborative Arthritis Centres: I. Structure, aims, and patients

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798296

Economic burden of rheumatoid arthritis: a systematic review

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798296

The friction cost method for measuring indirect costs of disease.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798296

A multicenter study of annual health service utilization and costs in rheumatoid arthritis.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798296

Locomotion status and costs in destructive rheumatoid arthritis. A comprehensive study of 82 patients from a population of 13,000

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798296

The costs of rheumatoid arthritis. a patient-oriented study of chronic disease costs

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798296

Employment across chronic inflammatory rheumatic diseases and comparison with the general population.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798296

Determinants of direct costs in Dutch rheumatoid arthritis patients

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798296

Longterm studies in rheumatoid arthritis--the German experience.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798296

Health economics research in the area of chronic polyarthritis

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798296

Indirect medical costs in early rheumatoid arthritis: composition of and changes in indirect costs within the first three years of disease.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798296

Total costs and predictors of costs in patients with systemic lupus erythematosus.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798296

Underestimating the value of women: assessing the indirect costs of women with systemic lupus erythematosus. Tri-Nation Study Group.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798296

An assessment of the annual and long-term direct costs of rheumatoid arthritis: the impact of poor function and functional decline

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798296

Direct cost of rheumatoid arthritis during the first six years: a cost-of-illness study.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798296

Direct and indirect medical costs incurred by Canadian patients with rheumatoid arthritis: a 12 year study.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798296

Direct medical costs unique to people with arthritis.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798296

A multicenter study of hospitalization in rheumatoid arthritis. Frequency, medical-surgical admissions, and charges

25 September 2018

1 reference

12 December 2020

[Comparative evaluation of a German version of the Health Assessment Questionnaire and the Hannover Functional Capacity Questionnaire]

1 reference

12 December 2020

Rheumatoid arthritis is already expensive during the first year of the disease (the Swedish TIRA project)

1 reference

12 December 2020

Costs and outcomes in rheumatoid arthritis and osteoarthritis

1 reference

12 December 2020

Identifiers

DOI

10.1136/ARD.2005.046367

1 reference

9 August 2017

1 reference

9 August 2017

1 reference